Skip to content

MICROBOT MEDICAL INC.: 10-K filed 2014-03-13

What MICROBOT MEDICAL INC. reported in its annual report filed 2014-03-13 (fiscal FY 2013): 39 published measures, 135 facts as tagged in accession 0001193125-14-097773.

This filing

Form
10-K (annual report)
Filed
2014-03-13
Fiscal period
fiscal FY 2013
Accession
0001193125-14-097773 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MICROBOT MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3141,557,174USD
At 2012-12-3130,170,277USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3126,603,462USD
At 2012-12-3116,185,660USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3114,953,712USD
At 2012-12-3113,984,617USD
At 2011-12-3110,725,124USD
At 2010-12-3115,480,629USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3130,585,424USD
At 2012-12-318,471,275USD
At 2011-12-3113,311,261USD
At 2010-12-3119,707,821USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-6,962,000USD92
2013-01-01 to 2013-12-31-26,439,159USD365
2013-07-01 to 2013-09-30-7,192,000USD92
2013-04-01 to 2013-06-30-5,869,000USD91
2013-01-01 to 2013-03-31-6,416,000USD90
2012-10-01 to 2012-12-31-2,758,000USD92
2012-01-01 to 2012-12-31-28,491,153USD366
2012-07-01 to 2012-09-30-16,337,000USD92
2012-04-01 to 2012-06-30833,000USD91
2012-01-01 to 2012-03-31-10,229,000USD91
2011-01-01 to 2011-12-31-21,328,538USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-23,322,001USD365
2012-01-01 to 2012-12-31-19,869,344USD366
2011-01-01 to 2011-12-31-22,058,283USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-314,680,796USD365
2012-01-01 to 2012-12-3173,083USD366
2011-01-01 to 2011-12-31296,933USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-10-01 to 2013-12-31313,000USD92
2013-01-01 to 2013-12-311,203,270USD365
2013-07-01 to 2013-09-30325,000USD92
2013-04-01 to 2013-06-30282,000USD91
2013-01-01 to 2013-03-31284,000USD90
2012-10-01 to 2012-12-31211,000USD92
2012-01-01 to 2012-12-311,367,955USD366
2012-07-01 to 2012-09-30264,000USD92
2012-04-01 to 2012-06-30249,000USD91
2012-01-01 to 2012-03-31644,000USD91
2011-01-01 to 2011-12-311,220,670USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3136,402,277USD365
2012-01-01 to 2012-12-3125,737,110USD366
2011-01-01 to 2011-12-3119,129,484USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-319,035,906USD365
2012-01-01 to 2012-12-31-10,691,831USD366
2011-01-01 to 2011-12-31-3,422,012USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-387,530,334USD
At 2012-12-31-361,091,175USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-315,304,684USD
At 2012-12-311,375,329USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,608,670USD365
2012-01-01 to 2012-12-312,878,134USD366
2011-01-01 to 2011-12-313,260,937USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-28,605,445USD365
2012-01-01 to 2012-12-31-22,545,676USD366
2011-01-01 to 2011-12-31-28,076,363USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3131,840,455USD
At 2012-12-3124,041,317USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,166,782USD365
2012-01-01 to 2012-12-3150,193USD366
2011-01-01 to 2011-12-3171,363USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-319,132,116USD
At 2012-12-315,097,132USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-311,151,903USD
At 2012-12-31999,365USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-12-312,139,294USD
At 2012-12-311,983,426USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-12-31108,815USD
At 2012-12-31110,159USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-10-01 to 2013-12-319,697,000USD92
2013-01-01 to 2013-12-3129,492,087USD365
2013-07-01 to 2013-09-306,895,000USD92
2013-04-01 to 2013-06-306,425,000USD91
2013-01-01 to 2013-03-316,475,000USD90
2012-10-01 to 2012-12-316,949,000USD92
2012-01-01 to 2012-12-3123,650,443USD366
2012-07-01 to 2012-09-305,269,000USD92
2012-04-01 to 2012-06-305,534,000USD91
2012-01-01 to 2012-03-315,898,000USD91
2011-01-01 to 2011-12-3129,082,222USD365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-01-01 to 2013-12-31886,642USD365
2012-01-01 to 2012-12-311,104,767USD366
2011-01-01 to 2011-12-311,005,859USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-01-01 to 2013-12-318,896,537USD365
2012-01-01 to 2012-12-317,447,235USD366
2011-01-01 to 2011-12-318,202,375USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-3120,533,713USD365
2012-01-01 to 2012-12-3115,846,829USD366
2011-01-01 to 2011-12-3119,937,764USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3155,138,311shares
At 2012-12-3137,506,305shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-31252,101USD
At 2012-12-31193,177USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-3115,191,132USD
At 2012-12-3110,708,677USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-319,886,448USD
At 2012-12-319,333,348USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-12-311,835,717USD
At 2012-12-311,822,904USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-31413,717USD
At 2012-12-31947,301USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-314,067,916USD
At 2012-12-312,707,441USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-12-31293,000USD
At 2012-12-31364,000USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-31789,000USD365
2012-01-01 to 2012-12-31728,000USD366
2011-01-01 to 2011-12-31842,000USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-12-311,058,725USD365
2012-01-01 to 2012-12-31991,721USD366
2011-01-01 to 2011-12-311,207,911USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-01-01 to 2013-12-31269,000USD365
2012-01-01 to 2012-12-31264,000USD366
2011-01-01 to 2011-12-31366,000USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-10-01 to 2013-12-312,508,000USD92
2013-01-01 to 2013-12-3168,497USD365
2013-07-01 to 2013-09-30-536,000USD92
2013-04-01 to 2013-06-30353,000USD91
2013-01-01 to 2013-03-31-159,000USD90
2012-10-01 to 2012-12-314,034,000USD92
2012-01-01 to 2012-12-3133,693USD366
2012-07-01 to 2012-09-30-11,260,000USD92
2012-04-01 to 2012-06-306,183,000USD91
2012-01-01 to 2012-03-31-4,903,000USD91
2011-01-01 to 2011-12-31109,404USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,166,286USD365
2012-01-01 to 2012-12-31-5,945,477USD366
2011-01-01 to 2011-12-316,747,825USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-12-3123,491,597USD365
2012-01-01 to 2012-12-3119,747,550USD366
2011-01-01 to 2011-12-3119,774,820USD365
2011-01-01 to 2011-01-319,400,000USD31

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-3,606USD365
2012-01-01 to 2012-12-3150,451USD366
2011-01-01 to 2011-12-31-67,974USD365

Inspect the source

Entity
MICROBOT MEDICAL INC. / CIK 0000883975
Captured
2026-09-20T05:02:19.185Z
SEC response SHA-256
5fc792c757c83821aa0cd636b3655419924829213ef914d8be1d9f56dce19054

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000883975.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))